{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:57:20Z","timestamp":1791575840042,"version":"4.3.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40264-024-01437-1","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T13:02:23Z","timestamp":1715173343000},"page":"921-923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7873-5483","authenticated-orcid":false,"given":"Antoine","family":"Pariente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Bres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Faillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"1437_CR1","first-page":"1383","volume":"182","author":"JL Imbs","year":"1998","unstructured":"Imbs JL, Castot A, Begaud B, Larousse C, Blayac JP, Alexandre JM. Le syst\u00e8me francais de pharmacovigilance [French system of drug surveillance]. Bull Acad Natl Med. 1998;182:1383\u201391.","journal-title":"Bull Acad Natl Med"},{"key":"1437_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/cpt.2266","volume":"110","author":"L L\u00e9tinier","year":"2021","unstructured":"L\u00e9tinier L, Jouganous J, Benkebil M, Bel-L\u00e9toile A, Goehrs C, Singier A, et al. Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions. Clin Pharmacol Ther. 2021;110:392\u2013400.","journal-title":"Clin Pharmacol Ther"},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40264-022-01157-4","volume":"45","author":"R Ball","year":"2022","unstructured":"Ball R, Dal Pan G. \u201cArtificial Intelligence\u201d for pharmacovigilance: ready for prime time? Drug Saf. 2022;45:429\u201338.","journal-title":"Drug Saf"},{"key":"1437_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s40264-023-01315-2","volume":"46","author":"H Wang","year":"2023","unstructured":"Wang H, Ding YJ, Luo Y. Future of ChatGPT in pharmacovigilance. Drug Saf. 2023;46:711\u20133.","journal-title":"Drug Saf"},{"key":"1437_CR5","doi-asserted-by":"publisher","DOI":"10.2196\/ijmr.5231","volume":"5","author":"S Lombardo","year":"2016","unstructured":"Lombardo S, Cosentino M. Internet use for searching information on medicines and disease: a community pharmacy-based survey among adult pharmacy customers. Interact J Med Res. 2016;5: e22. https:\/\/doi.org\/10.2196\/ijmr.5231.","journal-title":"Interact J Med Res."},{"key":"1437_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jama.2023.1044","volume":"329","author":"A Sarraju","year":"2023","unstructured":"Sarraju A, Bruemmer D, Van Iterson E, Cho L, Rodriguez F, Laffin L. Appropriateness of cardiovascular disease prevention recommendations obtained from a popular online chat-based artificial intelligence model. JAMA. 2023;329:842\u20134.","journal-title":"JAMA"},{"issue":"13","key":"1437_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMsr2214184","volume":"388","author":"P Lee","year":"2023","unstructured":"Lee P, Bubeck S, Petro J. Benefits, limits, and risks of GPT-4 as an AI Chatbot for medicine. N Engl J Med. 2023;388(13):1233\u20139.","journal-title":"N Engl J Med"},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10916-023-01925-4","volume":"47","author":"M Cascella","year":"2023","unstructured":"Cascella M, Montomoli J, Bellini V, Bignami E. Evaluating the feasibility of ChatGPT in healthcare: an analysis of multiple clinical and research scenarios. J Med Syst. 2023;47:33.","journal-title":"J Med Syst"},{"key":"1437_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2023-003750","author":"B Morath","year":"2023","unstructured":"Morath B, Chiriac U, Jaszkowski E, et al. Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis. Eur J Hosp Pharm. 2023. https:\/\/doi.org\/10.1136\/ejhpharm-2023-003750.","journal-title":"Eur J Hosp Pharm"},{"issue":"10","key":"1437_CR10","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00228-023-03547-8","volume":"79","author":"F Montastruc","year":"2023","unstructured":"Montastruc F, Storck W, de Canecaude C, Victor L, Li J, Cesbron C, Zelmat Y, Barus R. Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice. Eur J Clin Pharmacol. 2023;79(10):1375\u201384.","journal-title":"Eur J Clin Pharmacol"},{"key":"1437_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.therap.2022.11.004","volume":"78","author":"A Pariente","year":"2023","unstructured":"Pariente A, Micallef J, Lahouegue A, Molimard M, Auffret M, Chouchana L, et al. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations? Therapie. 2023;78:131\u201343.","journal-title":"Therapie"},{"key":"1437_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40290-019-00320-0","volume":"34","author":"R Ghosh","year":"2020","unstructured":"Ghosh R, Kempf D, Pufko A, Barrios Martinez LF, Davis CM, Sethi S. Automation opportunities in pharmacovigilance: an industry survey. Pharm Med. 2020;34:7\u201318.","journal-title":"Pharm Med."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-024-01437-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T14:23:50Z","timestamp":1723645430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-024-01437-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1007\/s40264-024-01437-1","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"21 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received to assist in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors declare they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AP, FS, VB, and JLF conceptualized the research questions and designed the study. All authors performed the queries and assessed the appropriateness of the responses. AP performed the statistical analyses and wrote the original draft. All authors contributed to data interpretation and editing of the draft and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}